88R14185 MPF-D
By: Guillen H.B. No. 3784
A BILL TO BE ENTITLED
AN ACT
relating to a task force to study methods for increasing the
manufacture of opioid antagonists.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
SECTION 1. (a) In this section:
(1) "Commission" means the Health and Human Services
Commission.
(2) "Executive commissioner" means the executive
commissioner of the Health and Human Services Commission.
(3) "Opioid antagonist" has the meaning assigned by
Section 483.101, Health and Safety Code.
(b) The commission, in coordination with the comptroller,
shall establish a task force to study methods to incentivize
manufacturers of opioid antagonists to increase production.
(c) The executive commissioner, in coordination with the
comptroller, shall determine the number of members on the task
force and appoint members to the task force accordingly.
(d) The executive commissioner and comptroller shall
jointly designate one member of the task force to serve as the
presiding officer.
(e) A member of the task force is not entitled to
compensation but is entitled to reimbursement for the member's
travel expenses as provided by Chapter 660, Government Code, and
the General Appropriations Act.
(f) Not later than December 1, 2024, the task force shall
submit a report to the legislature on its findings and
recommendations, including proposed legislation to increase the
manufacturing production of opioid antagonists.
(g) The task force is abolished and this Act expires on
January 1, 2025.
SECTION 2. As soon as practicable after the effective date
of this Act, the executive commissioner of the Health and Human
Services Commission shall appoint the members of the task force
established by this Act.
SECTION 3. This Act takes effect immediately if it receives
a vote of two-thirds of all the members elected to each house, as
provided by Section 39, Article III, Texas Constitution. If this
Act does not receive the vote necessary for immediate effect, this
Act takes effect September 1, 2023.